New York · 2025 Regular Session · Bill

S 5352: Requires notification by a prescriber or pharmacist of the substitution of one generic drug product for another generic drug product

In committee Last action January 7, 2026: REFERRED TO HIGHER EDUCATION

Plain-language summary

S 5352 is a bill introduced in the New York Senate on February 20, 2025. According to its official title, it concerns: Requires notification by a prescriber or pharmacist of the substitution of one generic drug product for another generic drug product. Primary sponsor: Leroy Comrie (Democratic). Most recent recorded action (January 7, 2026): REFERRED TO HIGHER EDUCATION.

Sponsors

Primary sponsor: Leroy Comrie (Democratic).